Mostra i principali dati dell'item
| dc.contributor.author | García Pedraza, José Ángel | |
| dc.contributor.author | García Domingo, Mónica | |
| dc.contributor.author | Martín Calvo, María Luisa | |
| dc.contributor.author | Gómez Escudero, Jesús | |
| dc.contributor.author | Rodríguez Barbero, Alicia | |
| dc.contributor.author | San Román, Luis | |
| dc.contributor.author | Morán Benito, Asunción | |
| dc.date.accessioned | 2024-11-13T08:06:32Z | |
| dc.date.available | 2024-11-13T08:06:32Z | |
| dc.date.issued | 2013-08-15 | |
| dc.identifier.citation | García-Pedraza JÁ, García M, Martín ML, Gómez-Escudero J, Rodríguez-Barbero A, Román LS, Morán A. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats. Eur J Pharmacol. 2013 Aug 15;714(1-3):65-73. doi: 10.1016/j.ejphar.2013.05.045. Epub 2013 Jun 11. PMID: 23769743. | es_ES |
| dc.identifier.issn | 0014-2999 | |
| dc.identifier.uri | http://hdl.handle.net/10366/160608 | |
| dc.description.abstract | 5-HT₂ receptor activation induces vasoconstriction, hypertension and platelet aggregation; therefore, its blocking may be useful in cardiovascular diseases, probably due to alterations in the modulation of serotonergic system. The aim of this study was to evaluate whether 5-HT₂ receptor blockade changes serotonergic modulation of sympathetic neurotransmission in pithed rats. Serotonergic modulation of sympathetic neurotransmission was investigated in Wistar rats treated with sarpogrelate, a 5-HT₂ receptor antagonist, during 14 days (30 mg/kg/day). After central nervous system destruction, we conducted electrical stimulation throughout the spinal cord flow to study the 5-HT-related products action on adrenergic system. 5-Hydroxytryptamine exerted inhibition of sympathetic outflow in sarpogrelate-treated pithed rats. This effect was mimicked and enhanced by 5-CT (5-HT₁/₇ receptor agonist). L-694,247 and AS-19, 5-HT₁D and 5-HT₇ receptor agonists respectively, reproduced this action. Pretreatment with LY310762+SB258719 (5-HT₁D and 5-HT₇ receptor antagonists, respectively) completely abolished 5-CT inhibitory action. The nature of this action was prejunctional since these agonists did not modify the pressor responses induced by exogenous noradrenaline. Western Blot analysis confirmed a higher expression of 5-HT₁D receptors in sarpogrelate-treated rats. Experimental 5-HT₂ receptor blockade induces changes in the 5-HT receptors involved in the serotonergic inhibition of sympathetic-induced pressor responses. Prejunctional activation of 5-HT₁D and 5-HT₇ receptors induces a significantly higher serotonergic inhibition on adrenergic neurotransmission in sarpogrelate-treated pithed rats. The antagonism of 5-HT₂ receptors produces an enhancement of serotonergic sympathoinhibitory effect, which may explain the beneficial effects of this blockade in cardiovascular disorders where 5-hydroxytryptamine plays a crucial role. | es_ES |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | eng | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | 5-HT | es_ES |
| dc.subject | 5-CT | es_ES |
| dc.subject | Sarpogrelate | es_ES |
| dc.subject | 5-HT2 receptors | es_ES |
| dc.subject | 5-HT1D receptors | es_ES |
| dc.subject | 5-HT7 receptors | es_ES |
| dc.subject | Prejunctional sympathoinhibition | es_ES |
| dc.subject | Pithed rat | es_ES |
| dc.subject.mesh | Rats | * |
| dc.subject.mesh | Serotonin Antagonists | * |
| dc.subject.mesh | Animals | * |
| dc.subject.mesh | Blood Vessels | * |
| dc.subject.mesh | Norepinephrine | * |
| dc.subject.mesh | Serotonin Receptor Agonists | * |
| dc.subject.mesh | Blood Pressure | * |
| dc.subject.mesh | Synaptic Transmission | * |
| dc.subject.mesh | Sympathetic Nervous System | * |
| dc.title | Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats. | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.1016/j.ejphar.2013.05.045 | |
| dc.subject.unesco | 3209 Farmacología | es_ES |
| dc.identifier.doi | 10.1016/j.ejphar.2013.05.045 | |
| dc.relation.projectID | SA017A10-2 | es_ES |
| dc.relation.projectID | 18.JA.7N/18.JB.7N | es_ES |
| dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | es_ES |
| dc.identifier.pmid | 23769743 | |
| dc.identifier.essn | 1879-0712 | |
| dc.volume.number | 714 | es_ES |
| dc.issue.number | 1-3 | es_ES |
| dc.page.initial | 65 | es_ES |
| dc.page.final | 73 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | presión sanguínea | * |
| dc.subject.decs | animales | * |
| dc.subject.decs | transmisión sináptica | * |
| dc.subject.decs | agonistas de receptores de serotonina | * |
| dc.subject.decs | ratas | * |
| dc.subject.decs | vasos sanguíneos | * |
| dc.subject.decs | norepinefrina | * |
| dc.subject.decs | antagonistas de la serotonina | * |
| dc.subject.decs | sistema nervioso simpático | * |








